Erdafitinib
Common Brand Names:
Balversa
Drug Class
Multikinase inhibitors
Animal-free Options?
Contact Pill Clarity for more information.
Indication
Treatment of adult patients with locally advanced or metastatic urothelial carcinoma (mUC) with susceptible FGFR3 genetic alterations whose disease has progressed on or after at least one line of prior systemic therapy
Why you need to contact us:
Formulations are subject to change, so it's important to consult your healthcare provider or the manufacturer. Our Pill Clarity pharmacists are here to assist. Please note that our product information is general and not a substitute for professional medical advice. Pill Clarity does not assess safety or efficacy of medications.
*The product and/or information provided on Pill Clarity is of a general nature and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. We do not lab test the products to confirm that they are free from animal ingredients, and it is possible that the formulation and ingredients could have changed. Pill Clarity does not assess safety or efficacy of medications. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition or product.